Cytek Biosciences Inc (CTKB)
Inventory turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 89,347 | 83,589 | 63,062 | 48,806 | 41,129 |
Inventory | US$ in thousands | 43,893 | 60,877 | 48,154 | 32,171 | 23,018 |
Inventory turnover | 2.04 | 1.37 | 1.31 | 1.52 | 1.79 |
December 31, 2024 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $89,347K ÷ $43,893K
= 2.04
Cytek Biosciences Inc's inventory turnover ratio has shown fluctuations over the past five years. The inventory turnover for the year ending December 31, 2020, was 1.79, indicating that the company sold its entire inventory almost twice during that year. However, by the year ending December 31, 2021, the ratio decreased to 1.52, suggesting a slight slowdown in inventory turnover.
In the subsequent years, the inventory turnover continued to decrease to 1.31 by December 31, 2022, before experiencing a slight uptick to 1.37 by December 31, 2023. Notably, by December 31, 2024, the inventory turnover ratio significantly increased to 2.04, indicating that Cytek Biosciences Inc was able to sell its inventory more efficiently during that year.
Overall, the trend in Cytek Biosciences Inc's inventory turnover suggests some fluctuations in the company's ability to efficiently manage its inventory levels and convert them into sales over the years. A higher inventory turnover ratio is generally preferred as it indicates that the company is selling goods quickly and efficiently, which can lead to improved liquidity and profitability.
Peer comparison
Dec 31, 2024